A Unified Framework for Measuring Corporate Social Responsibility in the Pharmaceutical Sector

Why It Matters

This research highlights a gap in how CSR is measured within the pharmaceutical sector, particularly in specific regions. By establishing a unified approach, companies can better communicate their commitment to social and environmental issues, fostering trust and potentially improving their overall brand reputation and market position.

Key Finding

The research found that pharmaceutical companies in the region have varied and often unstandardized ways of measuring their social and environmental impact, indicating a need for a more unified approach based on stakeholder theory.

Key Findings

• Limited and inconsistent application of CSR measurement systems in the pharmaceutical sector of the region.
• A need exists to differentiate and standardize indicators for economic, environmental, and social performance.
• Stakeholder theory provides a foundation for understanding the broader responsibilities of pharmaceutical companies.

Research Evidence

Aim: To analyze and propose a unified measurement system for Corporate Social Responsibility (CSR) within the pharmaceutical industry of a specific region, differentiating between economic, environmental, and social indicators.

Method: Mixed-methods research, including analytical methods, interviews, desk research, and statistical analysis.

Procedure: The study involved a detailed analysis of CSR measurement systems used by major pharmaceutical companies in four countries within the specified region, examining the indicators employed for economic, environmental, and social aspects.

Sample Size: 12 pharmaceutical companies

Context: Pharmaceutical industry in ex-Yugoslavian countries (Slovenia, Croatia, Serbia, Bosnia and Herzegovina, Macedonia).

Design Principle

Measure and report on the holistic impact of business operations, not just financial performance, to build trust and ensure long-term sustainability.

How to Apply

Companies can adapt the principles of stakeholder theory to develop their own CSR metrics, focusing on transparency and comprehensive reporting across all operational facets.

Limitations

The study is focused on a specific region and may not be directly generalizable to pharmaceutical industries in other geographical areas. The sample size, while representative of key players, is limited.

Student Guide (IB Design Technology)

Simple Explanation: Companies, especially in the drug industry, need a clear way to show they care about more than just making money. This study suggests a way to measure their good deeds for people and the planet, so everyone knows what they're doing.

Why This Matters: Understanding how to measure CSR helps in designing products and services that are not only functional and profitable but also ethically and environmentally sound, which is increasingly important to consumers and investors.

Critical Thinking: How can the 'success' of a design be measured if it has negative social or environmental consequences, even if it is highly profitable?

IA-Ready Paragraph: This research underscores the importance of a comprehensive approach to evaluating business performance, moving beyond purely economic indicators to encompass environmental and social responsibilities. By adopting a stakeholder-centric perspective, design projects can aim to create solutions that deliver value not only to the end-user but also to the wider community and ecosystem, fostering a more sustainable and ethical design practice.

Project Tips

• When researching a company's impact, look beyond their financial reports to their environmental and social initiatives.
• Consider how different groups (customers, employees, environment) are affected by a product or service.

How to Use in IA

• Use the concept of stakeholder theory to justify the importance of measuring broader impacts beyond profit in your design project.
• Analyze how different stakeholders might perceive the success of your design based on various metrics (e.g., usability, environmental footprint, cost).

Examiner Tips

• Demonstrate an understanding of how design decisions can have wider societal and environmental implications.
• Show how you have considered the needs and impacts on various stakeholders in your design process.

Independent Variable: CSR measurement systems (economic, environmental, social indicators).

Dependent Variable: Level of CSR adoption and consistency in the pharmaceutical industry.

Controlled Variables: Pharmaceutical companies within the specified region.

Strengths

• Addresses a specific, under-researched area within CSR.
• Employs a multi-country regional focus.
• Utilizes a mixed-methods approach for comprehensive analysis.

Critical Questions

• To what extent can a single measurement system truly capture the diverse impacts of CSR across different industries?
• How can the proposed unified framework be practically implemented by companies with varying resources and priorities?

Extended Essay Application

• Investigate the CSR practices of a specific company or industry and propose a tailored measurement system.
• Analyze the ethical implications of design choices and their impact on various stakeholder groups.

Source

A Measurement System Of Corporate Social Responsibility In The Pharmaceutical Industry Of The Region · International Journal of Management & Information Systems (IJMIS) · 2010 · 10.19030/ijmis.v14i5.13